Light-sensing Protein Could Explain Role of Seasons in MS Risk & Managing Good and Bad Days
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a light-sensing protein present in the brain during fetal development may help explain why MS is more common among...
8 Joulu 20219min
Tecfidera Excels at Reducing RRMS Relapse Rate & Managing the Bad Days with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or ...
6 Joulu 20218min
Stopping Fingolimod for Pregnancy Raises Relapse Risk & Singing Can Benefit People with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how women with relapsing-remitting MS who stop fingolimod – sold as Gilenya – to conceive or in early pregnancy have a...
3 Joulu 202112min
Jenn Powell Talks to MS Twins and Advocates Tamara Kahn and Terry Hord
Jenn Powell speaks with identical twins with MS Tamara Kahn and Terry Hord. Meet identical twins Tamara Kahn and Terry Hord. Identical in every way, both were diagnosed with multiple sclerosis twenty ...
2 Joulu 202139min
MS Could Increase Risk After Colorectal Diagnosis & Fertility and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that indicates how people who develop colorectal cancer are more likely to die from it if the...
1 Joulu 20218min
Anti-CD20 Therapies Show Similar Safety And Efficacy in RRMS & Wheelchair Mishap
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about how anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of ...
29 Marras 20219min
Oral Treatment Can Ease MS Bladder Problems & Could Mono Help Research MS?
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how oral fesoterodine fumarate tablets can reduce urinary disorders and improve quality of life for peop...
26 Marras 20218min
Vumerity Recommended for EU Approval as RRMS Therapy & Coping with Expected Loss
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how European Medicines Agency committee is recommending that Vumerity be approved for adults with...
24 Marras 20216min
